|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||48.14 / 151.05|
Prices have broken the lows of August and September so the trend has turned down.
Is Teladoc's merger with Livongo Health a 'game changer' for the stock?
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
These names combine healthcare research with state-of-the art technology.
Beware of high-flying stocks and instead opt for these 'grounded' ones.
It might be a good time to buy the stock because of its recent pullback, but there also is an ETF traders might consider if the telemedicine sector is of interest.
Wendy's, Regeneron and Teladoc -- why would you unload them now?
Instead of scratching your head and saying the market defies logic, look to the Cramer Covid-19 Index.
Our analysis and trading strategy on this 'wild bunch' stock.
Do these four make sense? The answer, surprisingly, is very much so if they continue to execute as well as they have.
The 'stay-at-home stock' rallied on Wednesday.
This is a name I think traders need to be in before sports actually get going if they want to catch the biggest portion of the short-term upside.
There are simply an immense number of health and technology and safety companies coupled with businesses that thrive when you have to stay home.
Here's a trade in the fast food name that's serving up amid the Covid-19 crisis.
Intraday trends -- relentless trends -- are becoming the name of the game, so let's focus on the rotation from Nasdaq names into the Russell 2000 and financials.
I would want to give this trade either a long time or look for a quick drop.
Things will be different after Covid-19 and one change will be in how people care about themselves.
LVGO went public in late July so we don't have a lot of price history.
I will be looking at some index shorts should the selling pressure continue into the afternoon.
I am carrying a large cash balance -- but not because I'm bearish.